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Abstract This study directly compares total intrafascial
laparoscopic (TAIL™) hysterectomy with vaginal (VH) and
abdominal (AH) hysterectomy with regard to safety,
operating time and time of convalescence. The study is a
prospective cohort study (Canadian Task Force classifica-
tion II-2), including data from patients of a single
university-affiliated teaching institution, admitted between
1997 and 2008 for hysterectomy due to benign uterus
pathology. Patient data were collected pre-, intra- and
postoperatively and complications documented using a
standardised data sheet of a Swiss obstetric and gynaeco-
logical study group (Arbeitsgemeinschaft Schweizerische
Frauenkliniken, Amlikon/Switzerland). Classification of
complications (major complications and minor complica-
tions) for all three operation techniques, evaluation of
surgeons and comparison of operation times and days of
hospitalisation were analysed. 3066 patients were included
in this study. 993 patients underwent AH, 642 VH and
1,431 total intrafascial hysterectomy. No statistically sig-
nificant difference for the operation times comparing the
three groups can be demonstrated. The mean hospital stay
in the TAIL™ hysterectomy, VH and AH groups is 5.8±
2.4, 8.8±4.0 and 10.4±3.9 days, respectively. The postop-
erative minor complications including infection rates are
low in the TAIL™ hysterectomy group (3.8%) when
compared with either the AH group (15.3%) or the VH
group (11.2%), respectively. The total of minor complica-
tions is statistically significant lower for TAIL™ hysterec-
tomy as for AH (O.R. 4.52, CI 3.25–6.31) or VH (O.R. 3.16,
CI 2.16–4.62). Major haemorrhage with consecutive reop-
eration isobserved statisticallysignificantlymore frequentin
the AH group when compared to the TAIL™ hysterectomy
group, with an O.R. of 6.13 (CI 3.05–12.62). Overall, major
intra- and postoperative complications occur significant
more frequently in the AH group (8.6%) when compared to
the VH group (3%) and the TAIL™ hysterectomy group
(1.8%). The incidence of major complications applying the
standardised TAIL™ hysterectomy technique is not related
to the experience of the surgeons. We conclude that a
standardised intrafascial technique of total laparoscopic
(TAIL™) hysterectomy using an anatomically developed
special uterine device is associated with a very low incidence
of minor and major intra- and postoperative complications.
The direct comparison of complication rates with either
vaginal or abdominal hysterectomy favours the total laparo-
scopic technique, and therefore, this technique can be
recommended as a relatively atraumatic procedure. The
operation times are comparable for all three techniques
without any statistically significant differences. This tech-
nique for laparoscopic hysterectomy is shown to be equally
safe when applied by experienced gynaecologic surgeons or
by residents in training.
Keywords Total intrafascial laparoscopic hysterectomy.
TAIL™ hysterectomy.Vaginal hysterectomy.Abdominal
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A recent Cochrane review of 27 randomised controlled
trials with 3,643 patients [1] comparing different techniques
of hysterectomy in benign gynaecologic disease has shown
that patients undergoing laparoscopically assisted vaginal
hysterectomy (LAVH) or total laparoscopic hysterectomy
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drop in haemoglobin), significantly less infections and a
faster return to normal activities when compared to
laparotomy. On the other hand, abdominal hysterectomy
(AH) requires a significantly lower operating time, and
the frequency of urinary tract injuries is significantly
increased for LH or LAVH [1]. The laparoscopic
technique had no advantage over vaginal hysterectomy
(VH) since in all but two studies LAVH was performed. In
this situation, the most important steps of the operation are
identical with VH.
The importance of more frequent urinary tract injuries,
especially ureteral lesions, when applying the LH or the
LAVH technique is supported by a non-randomised but
large published database [2]. It is therefore possible that
fear of consecutive complications and technical difficulties
are the reasons for the fact that the vast majority of
hysterectomies of benign uterus disease are today still
performed as abdominal laparotomies [3–6]. In contrast,
recent published data of a series of 3,190 LH for benign
uterus disease by Donnez et al. [7] clearly demonstrated
that this technique is a safe alternative with no increase in
major complications when applied by experienced sur-
geons. LH also was shown to be associated with less tissue
trauma [8], less postoperative pain [9], lower morbidity and
less stress response when compared to AH [10].
In 1992, we started the development of a device and a
surgical technique with the aim to improve safety and to
simplify total LH [11]. The instrument described is
reusable. It has been developed further and is manufactured
today by Storz AG, Tuttlingen/Germany. Preliminary
experience with this instrument has been reported by
different authors [12–14].
The study presented evaluates safety and feasibility of a
standardised surgical technique for total intrafascial laparo-
scopic (TAIL™) hysterectomy using the developed surgical
device. We compare data of TAIL™ hysterectomy with AH
and VH in a large group of patients (3,066 patients) from
one single teaching institution.
Material and methods
Patients
All patients admitted between 1997 and 2008 for hysterec-
tomy with or without adnexectomy due to benign uterine
disease were included in this prospective, cohort study.
Patient data were collected prospectively pre-, intra- and
postoperative. Complications were documented using a
standardised data sheet of a Swiss obstetric and gynaeco-
logical study group (Arbeitsgemeinschaft Schweizerische
Frauenkliniken, Amlikon/Switzerland) [15]. Inclusion and
exclusion criteria as well as the outcome were defined. For
the analysis, patient identification was removed.
The quality of the data recorded was ensured by a two-
step control system. First, the completeness and exactness
of all data were verified at our centre by a data controller
and double checked by a senior gynaecologist. Then, the
data were sent to the central registry of the Swiss study
group, and there, the accuracy of all data entered in the
database was assessed again by the data centre quality
control group. In case of discrepancy, data were returned
for verification and correction. Information on patient
characteristics, surgical procedures, intra- and postoperative
complications was documented in the database.
The choice of the operative procedure (AH, VH or
TAIL™ hysterectomy) was based on patient preferences
after a thorough discussion of risks and benefits. Compli-
cations were classified as previously reported [16] with
some minor modifications.
Major complications were classified as follows:
& Major haemorrhage: requiring transfusion or reoperation
& Bowel, ureteric or bladder injury
& Deep venous thrombosis and pulmonary embolus (diag-
nosed by ultrasound, angiography, perfusion/ventilation
scintigraphy or CT scan)
& Reoperation for postoperative bleeding or unintended
laparotomy
Minor complications were defined as:
& Infections (pelvic infection or fever >38°C, two
consecutive days)
& Abdominal or vaginal bleeding or haematoma not
requiring reoperation
& Ileus
& Wound dehiscence
& Significant bacteruria
The study was approved by the ethical committee of
the Institutional Review Board, Kantonsspital Baden,
Switzerland.
Surgical technique
All vaginal and abdominal hysterectomies were performed
with a standard surgical technique [17]. Patients in the LH
group were operated by application of a step-by-step
standardised operation technique, the so-called total atrau-
matic intrafascial laparoscopic hysterectomy (TAIL™
hysterectomy). A totally reusable instrument (Hohl Manip-
ulator, Storz AG, Tuttlingen/Germany) with an anatomical
design as a uterine device was used in all patients being
operated by the LH technique. The instrument consists of a
strong handle, manipulator rod, cervical cup platform in
three different sizes for small, medium and large cervices,
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endocervical fixation of the instrument and Hegar-type
rod extensions for small and large uteri (Fig. 1 and Video
1). Tight endocervical fixation of the thread allows moving
even a large uterus in all directions and applying strong
tension to the tissue.
The cervical cup withstands electric and sonar energy
and delineates exactly the border between the vagina and
cervix. It serves as a surgical platform. Crucial surgical
steps, e.g. bicoagulation of uterine vessels and intrafascial
detachment of ligaments and vagina, are all performed in
direct contact with the fringe of the cup (Video 2). These
cups have a special design to adapt to the anatomy of the
anterior and posterior vaginal fornices (Fig. 1).
The patient is positioned in laparoscopic dorsal lithoto-
my position. Buttocks have to be positioned on the lower
edge of the operation table to allow free manipulation with
the instrument in all directions. The patient’s position is
maintained by the use of shoulder supports and in recent
years by special retraining mattresses on the operation
table. Cranial sliding even in deep Trendelenburg position
is thus mostly prevented. A tenaculum is placed on the
anterior lip of the cervix and the cervix is dilated to Hegar
6. The length of the uterus cavity is measured. The size of
the spiral thread is chosen according to the dimensions of
the cervical canal (wide or narrow) and Hegar-type rod
extensions according to uterine cavity length. Then, spiral
threads are very tightly screwed into the endocervix to
move even large uteri in all directions and apply strong
tension to the tissues. The manipulator handpiece with an
attached cup is gently introduced into the vagina with light
rotating movements (Fig. 2). It has to be ensured that the
extended side of the manipulator cup is located dorsally.
Only after the manipulator handpiece has been advanced
cranially as far as possible it is screwed to the manipulator
probe. As a result, the edge of the manipulator cup is
exactly located at the boundary of the cervix and the vagina
(Video 1).
A 10-mm port is placed in the umbilicus or even cranial
to the umbilicus in cases of very large uteri. Three
secondary 5-mm (two on the left side and one on the right
side) ports are positioned very laterally for the application
of surgical instruments. A 30° optical system is used for
navigation in cases with large uteri. Using this optical
system, better access to the ligaments is achieved. Bipolar
or vapor pulse coagulation (VPC-Gyrus PlasmaKinetic®)
applied with a grasping forceps with an integrated scalpel
or bipolar and monopolar forceps or hooks are used for the
dissection of the tissues.
Step 1. The uterine device is pushed strongly to the
contralateral side to create maximal tension. The
left utero ovarian ligament, fallopian tube and
the round ligament are grasped stepwise for
dissection.
Step 2. The anterior leaf of the peritoneum is incised and
dissected stepwise in the direction of the cervix.
The vesicovaginal peritoneum is opened and dis-
sected. If there was no previous caesarean section,
the dissection of the bladder from the cervix is
obviated by strong pressure on the uterine instru-
ment to push the uterus into the cranial direction
(Fig. 3).
Step 3. Steps 1 and 2 are performed on the right side in
analogy to the left side.
Step 4. With large uteri, access to the ligaments and
posterior fornix is often blocked. Therefore, we
approach the uterine arteries anteriorly. The
manipulator cup is rotated to the contralateral
side of the uterine artery (e.g. to the right side
when the left uterine artery is dissected) which is
then grasped whilst the back of the electric
instrument touches the fringe of the cup (in safe
distance from ureter and bladder, Fig. 4). Dis-
section of the uterine artery can therefore be
performed safely even in difficult anatomical
situations, e.g. frozen pelvis or advanced endo-
metriosis. In this way, blood circulation to the
uterus is completely stopped.
Fig. 1 Uterine manipulator with cup, thread, extension, rod and
handle
Fig. 2 Application of the uterine device
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and posterior ligaments may then be reduced in
volume without any further blood loss using an
electrical morcellator before cervical detachment.
Vaginal manipulation of the uterus in all directions
greatly facilitates morcellation (sometimes pulling
the uterus towards the vagina).
Step 6. The fringe of the cup used serves as a platform to
navigate around the cervix. If there are adhesions
of the rectum cranial to the vaginal line of inci-
sion, they must be lysed first. This is facilitated by
stretching tissues by applying strong pressure on
the cup of the device.
Step 7. Cardinal and sacrouterine ligaments are stretched
to a maximum applying strong cranial pressure.
The extraserosal pelvic fascia can be dissected at
the level of the paracervix [18], keeping the
“fascial ring” completely intact (Fig. 5). The
vagina is dissected following exactly the fringe
of the cup using monopolar blended current
applied by scissors or a hook. The pneumo-
peritoneum is still maintained through maximal
pressure on the vaginal walls by the device. After
complete detachment of the uterus, it is partially
removed from the vagina but left in the vaginal
canal to maintain the pneumoperitoneum until
laparoscopic suturing is accomplished.
Step 8. Usually three to four Z-sutures, using 1–0
polydiaxonon (PDS, Ethicon), incorporating car-
dinal and sacrouterine ligaments as well as
posterior and anterior endopelvic fascia are
needed to close the vagina. The sutures are
knotted extracorporally (Fig. 6). A “face-to-face”
closure of the fascial plane is strived for. With
our technique, we remove the uterus intrafas-
cially, but during closure, a shortening of the
ligaments can be achieved if the tissue is very lax
by placing extra sutures on the sacrouterine
ligaments and vagina. Bipolar coagulation should
be avoided whenever possible. The peritoneum
remains open. Hemostasis is checked and a
copious lavage using warm ringer lactate is done.
Fig. 4 Anterior approach to the uterine arteries. The back of the
bicoagulation instrument touches the fringe of the cup
Fig. 5 Intrafascial detachment of the uterus from ligaments and the
vagina
Fig. 3 Strong cranial pressure to the uterine device obviates the need
for bladder dissection
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Video 1 and Video 2 added to this publication.
Statistical analysis
Data were evaluated for normal distribution by Kolmo-
gorov–Smirnov test, and non-parametric tests were applied
if required. Statistical significance level was placed at 0.025
by the Bonferroni correction for comparison of groups.
Statistical evaluations were obtained by SPSS 10.0.7
Chicago Illinois, Medcalc 9.3.0.0 Belgium or Statcalc 5.0.
Results
A total of 3,066 patients fulfilled the inclusion criteria and
could be included in this study. 993 of the total number of
patients underwent AH, 642 VH and 1,431 TAIL™
hysterectomy. Table 1 shows the characteristics of the
patients, including age, body mass index, operation times
and duration of hospital stays. Mean age shows a difference
between the groups. The women in the TAIL™ hysterec-
tomy group are statistically significantly older when
compared to the AH and VH groups. Mean body mass
index also differs between the three groups. It is signifi-
cantly lower in the TAIL™ hysterectomy group compared
to the VH and AH groups. There is no statistically
significant difference for the operation times comparing
the three groups. The mean hospital stay in the TAIL™
hysterectomy, VH and AH groups is 5.8±2.4, 8.8±4.0 and
10.4±3.9 days, respectively. Statistically significant differ-
ences are demonstrated.
Table 2 shows the symptoms and diagnoses for the three
groups of patients. Dysfunctional uterine bleeding, cervical
intraepithelial neoplasia and genital prolapse are more
frequent in the VH group as compared to the TAIL™
hysterectomy group, whereas the frequency of the diagnosis
of postmenopausal bleeding, uterus myomatosus, benign
adnexal tumours and endometrioses is higher in the TAIL™
hysterectomy group than in the VH group.
Major complications are shown in Table 3.M a j o r
haemorrhage with consecutive reoperation is observed to
be statistically significantly more frequent in the AH group
when compared to the TAIL™ hysterectomy group, with an
O.R. of 6.13 (CI 3.05–12.62). An analogous observation is
described when the AH group is compared to the VH group
(O.R. 3.0, CI 1.45–6.39). For thromboembolic complica-
tions, a statistically significant difference is found: The AH
Fig. 6 Closure of the vagina and reconstruction of the fascia by face-
to-face closure
Table 1 Demographic and operative characteristics
TAIL™ hysterectomy AH (n=642) VH (n=642) Comparison
TAIL™-AH Tail™-VH AH-VH
Age (years) 56.4±14.5 50.0±11.1 46.9±8.9 p<0.01 p<0.01 p<0.01
Body mass index 24.9±2.8 26.7±3.5 27.1±2.9 p<0.01 p<0.01 n.s.
Operation time (min)
0–30 12 (0.8%) 5 (0.5%) 16 (2.5%) n.s. n.s. n.s.
31–60 272 (19%) 165 (17%) 167 (26%) n.s. n.s. n.s.
61–120 739 (52%) 481 (48%) 322 (50%) n.s. n.s. n.s.
121–180 333 (22%) 264 (26.5%) 112 (17%) n.s. n.s. n.s.
>180 75 (5.2%) 78 (8%) 25 (3.9%) n.s. n.s. n.s.
Hospital stay (days) 5.8±2.4 10.4±3.9 8.8±4.0 p<0.025 p<0.025 p<0.01
Data are reported as mean ± SD or number (%)
n.s.: p>0.025
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when compared to the TAIL™ hysterectomy group, with an
O.R. of 16.0 (CI 2.06–124). The total rate of reoperations
needed is significantly increased in the AH group when
compared to the TAIL™ hysterectomy group (O.R. 4.47,
CI 2.35–8.63), and also the AH group compared to the VH
group shows a statistically significant difference (O.R. 2.42,
CI 1.1–5.34).
Overall, major intra- and postoperative complications
occur significantly more frequently in the AH group (8.6%)
when compared to the VH group (3%) and the TAIL™
hysterectomy group (1.8%). No statistically significant
difference is shown for the comparison of the VH group
with the TAIL™ hysterectomy group. The odds ratios and
confidence intervals for major complications are 5.06 (CI
3.17–8.12) for AH compared to TAIL™ hysterectomy and
3.07 (CI 1.8–5.3) for AH compared to VH, respectively.
Table 4 demonstrates minor complications observed for
the three groups, including comparisons of the groups. The
postoperative minor complications including infection rates
(pelvic infections, fever and significant bacteruria) are low in
the TAIL™ hysterectomy group (3.8%) when compared
with either the AH group (15.3%) or the VH group (11.2%),
respectively. The total of minor complications is statistically
significantly lower for TAIL™ hysterectomy as for AH (O.
R. 4.52, CI 3.25–6.31) or VH (O.R. 3.16, CI 2.16–4.62).
Overall, the incidence of major and minor complications is
lowest in the TAIL™ hysterectomy group compared to either
AH or VH, respectively. The odds ratios and CI are 5.22
(3.97–6.89) for AH compared to TAIL™ hysterectomy, 2.75
(1.98–3.82) for VH compared to TAIL™ hysterectomy and
1.90 (1.49–2.50) for AH compared to VH.
The incidence of major complications applying the
standardised TAIL™ hysterectomy technique is not related
TAIL (n=1,431) AH (n=993) VH (n=642)
Dysfunctional uterine bleeding 655 (45.7%) 412 (41.5%) 349 (54.4%)
Postmenopausal bleeding 109 (7.6%) 69 (7%) 31 (4.8%)
Cervical intraepithelial neoplasie 65 (4.5%) 32 (3.2%) 64 (10%)
Adenomyosis 221 (15.4%) 141 (14.2%) 82 (12.7%)
Uterus myomatosus 758 (52.9%) 506 (51%) 240 (37.4%)
Benign adnexal tumours 131 (9.2%) 107 (10.8%) 9 (1.4%)
Genital prolapse 156 (10.9%) 145 (14.6%) 120 (18.7%)
Incontinence 115 (8%) 60 (6%) 52 (8.1%)
Endometriosis 122 (8.5%) 88 (8.9%) 10 (1.5%)
Dysmenorrhea 241 (16.8%) 70 (7%) 128 (19.9%)
Dyspareunia 62 (4.3%) 47 (4.7%) 30 (4.7%)
Abdominal pain 25 (1.7%) 21 (2.1%) 11 (1.7%)
Miscellaneous 45 (3.1%) 29 (2.9%) 21 (3.3%)
Table 2 Symptoms and
diagnoses
Patients may have multiple
symptoms and/or diagnoses
Table 3 Major complications
TAIL™ hysterectomy AH VH AH vs TAIL™ VH vs TAIL™ AH vs VH
1432 patients 993 patients 642 patients O.R.±95% CI O.R.±95% CI O.R.±95% CI
Major haemorrhage
(reoperations)
11 45 10 6.13 (3.05–12.62) n.s. 3.0 (1.45–6.39)
Bowel injury 2 4 1 n.s. n.s. n.s.
Ureteric injury 1 3 0 n.s. n.s. n.s.
Bladder injury 8 8 5 n.s. n.s. n.s.
Thromboembolic
complications
1 11 1 16.0 (2.06–124) n.s. n.s.
Reoperations 3 14 2 4.47 (2.353–8.63) n.s. 2.42 (1.1–5.34)
Total of complications 26 (1.8%) 85 (8.6%) 19 (3%) 5.06 (3.17–8.12) n.s. 3.07 (1.8–5.3)
At least one major
complication
22 (1.5%) 72 (7.3%) 17 (2.7%) 5.01 (3.02–8.38) n.s. 2.87 (1.63–5.11)
Values are numbers (percentage) of patients
A patient may have more than one complication
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among residents in training and experienced staff surgeons
for major complications. These data are summarised in
Table 5.
Discussion
The presented data are one of the largest prospective
observational studies from a single institution. We describe
and compare different techniques for total hysterectomy in
benign uterus disease. Although there are statistically signif-
icant differences in age and body mass index, we feel that
these are not in favour of total atraumatic intrafascial
laparoscopic (TAIL™) hysterectomy since patients in this
group are older. We demonstrate operation times not to vary
statistically significantly for the three groups analysed. This
observation is not in accordance with earlier published data of
other authors [1]. If the standardised surgical technique for
LH, as we describe it in this publication, is applied strictly,
the operating procedure is straightforward and operation
times are less as described for, e.g. LAVH procedures.
Therefore, total laparoscopic hysterectomy does not con-
sume longer operation times than either AH or VH,
respectively. As it has been shown in earlier publications,
LH is associated with less tissue trauma [8], less postoper-
ative pain [9], lower morbidity and less stress response when
compared to AH [10]. This leads to a better acceptance of
the procedure and an improvement of quality of life.
Symptoms and diagnoses with regard to dysfunctional
uterine bleeding, cervical intraepithelial neoplasia, genital
prolapse, postmenopausal bleeding, uterus myomatosus,
benign adnexal tumours and endometrioses are not equally
balanced for the LH and the VH groups. This is in accordance
with the published data by David-Montefiore et.al. [19]a n d
also reflects that in the first years of this study, LH was not
yet propagated and accepted as a standard of care for the
symptoms and diagnoses mentioned.
Optimising health economics by the development of safe
and time-saving operation techniques with reduced time of
convalescence and hospital treatment days, we present the
method of total relatively atraumatic intrafascial laparo-
Table 4 Minor complications
TAIL™
hysterectomy
AH VH AH vs TAIL™ VH vs TAIL™ AH vs VH
1431 patients 993 patients 642 patients O.R.±95% CI O.R.±95% CI O.R.±95% CI
Infection 14 42 15 4.47 (2.35–8.63) 2.42 (1.10–5.34) n.s.
Ileus 1 3 1 n.s. n.s. n.s.
Wound dehiscence 1 2 1 n.s. n.s. n.s.
Hematoma, bleeding
(not requiring reoperation)
6 7 9 n.s. 3.38 (1.16–9.53) n.s.
Significant bacteruria 33 98 46 4.64 (3.05–7.09) 3.27 (2.02–5.59) n.s.
Total 55 (3.8%) 152 (15.3%) 72 (11.2%) 4.52 (3.25–6.31) 3.16 (2.16–4.62) 1.43 (1.05–1.95)
At least one minor
complication
49 (3.4%) 125 (12.6%) 63 (9.8%) 4.06 (2.95–5.8) 3.07 (2.05–4.69) n.s.
Total of major and minor
complications
81 (5.7%) 237 (23.9%) 91 (14.2%) 5.22 (3.97–6.89) 2.75 (1.98–3.82) 1.90 (1.49–2.5)
Values are numbers (percentage) of patients
Table 5 Experience of surgeons and incidence of major complications with TAIL™ hysterectomy
Major complications Residents in training(620 patients) Staff surgeons (821 patients) Statistic level
Major haemorrhage 6 5 n.s.
Bowel injury 0 2 n.s.
Ureter injury 0 1 n.s.
Bladder injury 5 3 n.s.
Thromboembolic complications 1 0 n.s.
Reoperations 0 3 n.s.
Total 12 (1.9 ) 14 (1.7%) n.s.
n.s.: p>0.05
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demonstrate that the operation time is equivalent when
compared to AH and VH techniques. The mean hospital
treatment days are reduced from 9 to 10 days below 6 days.
As published evidence shows [1], reduced postoperative
time of convalescence and earlier return to work and social
life can be expected. The same is true for the quality of life
of patients [20]. Therefore, shorter hospitalisation time,
earlier convalescence, less lost work days and earlier return
to social life achieved by the use of this operation technique
support health economic aspects.
The main outcome results concerning intra- and postop-
erative complications are at variance with other published
reports. The most dreaded complication—the risk of
ureteric lesions—has repeatedly been shown to be increased
applying the laparoscopic hysterectomy technique as
compared to abdominal procedures [1, 2, 16, 21]. In
contrast, we demonstrate that the laparoscopic approach is
associated with a very low incidence of these complications
discussed. We describe the development and consequent
application of a uterine device designed to facilitate the
single operation steps increasing especially the safety of the
operation technique. The following step-by-step operation
protocol as described here is essential to achieve the results
presented for fast operation times with low incidences of
complications. Every potential “dangerous” step of the
operation procedure, e.g. the dissection of the uterine vessels,
is performed in direct contact with the surgical platform. The
device is designed to remove the bladder and ureter far away
from the dissection plane. Our LH method is an intrafascial
technique. This is also essential to increase the safety of the
operation. Intrafascial detachment of the cervix decreases the
risk for ureteral and/or bladder injuries even under difficult
conditions, e.g. large uteri or the situation of a frozen pelvis.
As described, there is no need for dissection of the bladder
from the vagina; this is another advantage using this
technique. In our study population, eight bladder lesions
(0.6%) occurred in patients with scarring of the lower uterine
segment after caesarean section. This is in accordance with
published data for AH and VH and does, also in our study
population, not show any statistically significant difference
when compared to the AH and VH groups. Our results are
also supported by the recent published data of a large series of
LH demonstrating no association with an increase of major
complication rates [7].
The analysed major complications include bleeding,
defined as the need of reoperation and the requirement of
blood transfusions. In our population, this complication is
documented significantly more frequently for AH than for
TAIL™ hysterectomy (OR 6.13 (CI 3.05–12.62). This
observation can be explained by the anatomic dissection
and the relatively atraumatic technique of the TAIL™
hysterectomy.
In contrast to Garry et al. [16] who found no significant
differences for the postoperative minor complications
including infection rates. In our study, these are signifi-
cantly lower in the LH group (3.8%) as either in the AH
(15.3%) or VH (11.2%) group. These data demonstrate that
our LH technique is applicable and safe if the developed
uterine device is applied correctly and used as a surgical
platform and if the operation is followed step-by-step
consequently as described. The face-to-face sutured endo-
pelvic fascia at the vaginal level might help prevent
postoperative ascending infections. Also, this tight approx-
imation of fascial tissue might promote fibroblast prolifer-
ation and help in sealing the wound and probably prevents
postoperative ascending infections. The short operation
times and the avoidance of extensive coagulation seem to
be important too.
With the technique of intrafascial dissection of the
cervix, most parts of the cardinal and sacrouterine liga-
ments remain attached. The vaginal closure by the use of
laparoscopic sutures unifies the ligaments, and during
closure, a shortening of the ligaments can be achieved, if
the tissue is very lax, by placing extra sutures on the
sacrouterine ligaments and vagina. This operation step
might contribute to a reduction of the indecency of post-
hysterectomy vaginal vault prolapse. This hypothesis,
however, needs to be confirmed by a long follow-up.
In summary, we observe, in contrast to others, a
statistically significantly lower incidence of complications
in the TAIL™ hysterectomy group when compared to
either vaginal or abdominal procedures. We acknowledge
that our results might be biased by the fact that our data
represent a prospective observational study and not a
randomised trial. However, the clinical importance of our
findings is underlined by the large number of patients. In
addition, our data are supported by the results of Donnez
et al. [7] demonstrating no increased major complication
rate for LH in a similar huge patient population as
presented in our study. All our patient data were collected
in a single institution, including staff surgeons and residents
in training as gynaecologic surgeons. The analysis of the
data presented shows no difference in the incidence of
complications comparing residents in training as surgeons
with experienced gynaecologic surgeons. This again is in
contrast to the experience of other authors [22–24]. We
postulate that the consequent following of the step-by-step
operation procedure is crucial to guarantee a long-term high
quality of outcome. The strict application of the stand-
ardised technique is a prerequisite for effective teaching and
learning of this surgical technique.
The presented data will encourage and serve as a strong
argument for better acceptance of the total laparoscopic
hysterectomy technique among gynaecologists as discussed
earlier in the literature [5]. Therefore, they serve as a
238 Gynecol Surg (2010) 7:231–239fundament and raise the potential of this technique to
popularise the minimal invasive approach. Thus, patients
with benign uterus disorders may benefit from the proven
advantages, e.g. less perioperative blood loss, reduction of
postoperative pain, lower incidence of postoperative infec-
tions and shorter convalescence, respectively, without under-
going an increased risk for perioperative complications.
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